Skip to main content
logo
Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.035
-0.115 (-5.35%)
At close: Nov 6, 2025, 4:00 PM EST
1.600
-0.435 (-21.39%)
After-hours: Nov 6, 2025, 7:59 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Biocatalysts, Pharmaceutical Intermediates, and Codex Biocatalyst Panels and Kits
36.79M
Log In
Log In
Log In
Log In
Upgrade
Biocatalysts, Pharmaceutical Intermediates, and Codex Biocatalyst Panels and Kits Growth
-14.26%
Log In
Log In
Log In
Log In
Upgrade
Research and Development
22.56M
Log In
Log In
Log In
Log In
Upgrade
Research and Development Growth
-17.18%
Log In
Log In
Log In
Log In
Upgrade
Performance Enzymes
-
Log In
Log In
Log In
Log In
Upgrade
Performance Enzymes Growth
-
Log In
Log In
Log In
Log In
Upgrade
Novel Biotherapeutics
-
Log In
Log In
Log In
Log In
Upgrade
Novel Biotherapeutics Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202005 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2005 - 2019
Americas
21.28M
Log In
Log In
Log In
Log In
Upgrade
Americas Growth
54.94%
Log In
Log In
Log In
Log In
Upgrade
China
9.80M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-51.72%
Log In
Log In
Log In
Log In
Upgrade
India
7.30M
Log In
Log In
Log In
Log In
Upgrade
Singapore
6.20M
Log In
Log In
Log In
Log In
Upgrade
EMEA
5.16M
Log In
Log In
Log In
Log In
Upgrade
EMEA Growth
-54.37%
Log In
Log In
Log In
Log In
Upgrade
APAC
4.41M
Log In
Log In
Log In
Log In
Upgrade
APAC Growth
-66.61%
Log In
Log In
Log In
Log In
Upgrade
Switzerland
3.40M
Log In
Log In
Log In
Log In
Upgrade
Switzerland Growth
-69.37%
Log In
Log In
Log In
Log In
Upgrade
Ireland
1.80M
Log In
Log In
Log In
Log In
Upgrade
Ireland Growth
260.00%
Log In
Log In
Log In
Log In
Upgrade